This Tuesday, 29/12/2020, the Basque Government approved the first version of the programme Euskadi Next 21-26, for the recovery, transformation and resilience of Euskadi..The Basque Government...
The PRAP EUSKADI initiative is now available for companies interested in monitoring the incidence of COVID-19 within their organisation..PRAP EUSKADI is an initiative supported by the Department...
[vc_row][vc_column][vc_column_text]On the occasion of the tenth anniversary of the Basque Health Cluster, we interviewed representatives of our members to explain their contributions to the cluster...
The e-Health firm AcceXible, a member of the Basque Health Cluster, has won the Expansión newspaper award in the Health and Biotechnology category sponsored by Novartis-Sandoz..AcceXible has...
Osakidetza and the Basque bio-pharmaceutical company, Histocell (member of the Basque Health Cluster) have successfully completed the first phase of the clinical trial for the drug HC016 for the...
The Basque Health Cluster member VIVEbiotech has been declared the winner of the Gipuzkoa 2020 Small Business Award, run by the Spanish Chamber of Commerce and Banco Santander..The prize giving took...
[vc_row][vc_column][vc_column_text]In 2000, the Basque Government advocated a decisive boost to the Basque economy in order to adapt to an increasingly changing and competitive world, making a...
The development of the ISMORE system has been acknowledged under the “Impact Expected” category of the EARTO Awards..The technological centre and Basque Health Cluster member Tecnalia has...
The German pharmaceutical firm has acquired US company AskBio, the 50% stakeholder of Viralgen with private equity fund Columbus..This is the strategy that BAYER is using to move into the innovative...
On 8 October the Basque Health Cluster was invited to a meeting in Lakua with the Regional Councillor for Economic Development, Sustainability and Environment, Arantxa Tapia, the Deputy Councillor...
THESE ARE THE PRIORITY GOALS TO BE BACKED BY THE BASQUE GOVERNMENT. UNEMPLOYMENT UNDER 10%, GDP OVER 40% IN ADVANCED INDUSTRY AND SERVICES, AND R&D IN LINE WITH THE EU AVERAGE.
